These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 19137292)
41. In vitro binding characteristics of [3H]AZ11637326, a novel alpha7-selective neuronal nicotinic receptor agonist radioligand. Gordon JC; Phillips E; Gurley DA; Heys JR; Lazor LA; Barthlow HG; Mallamaci MA; Keith RA Eur J Pharmacol; 2010 Oct; 645(1-3):63-9. PubMed ID: 20674564 [TBL] [Abstract][Full Text] [Related]
42. Fluorine-18-FPH for PET imaging of nicotinic acetylcholine receptors. Horti A; Scheffel U; Stathis M; Finley P; Ravert HT; London ED; Dannals RF J Nucl Med; 1997 Aug; 38(8):1260-5. PubMed ID: 9255161 [TBL] [Abstract][Full Text] [Related]
43. PET imaging of high-affinity α4β2 nicotinic acetylcholine receptors in humans with 18F-AZAN, a radioligand with optimal brain kinetics. Wong DF; Kuwabara H; Kim J; Brasic JR; Chamroonrat W; Gao Y; Valentine H; Willis W; Mathur A; McCaul ME; Wand G; Gean EG; Dannals RF; Horti AG J Nucl Med; 2013 Aug; 54(8):1308-14. PubMed ID: 23801676 [TBL] [Abstract][Full Text] [Related]
44. Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia. Wong DF; Kuwabara H; Horti AG; Roberts JM; Nandi A; Cascella N; Brasic J; Weerts EM; Kitzmiller K; Phan JA; Gapasin L; Sawa A; Valentine H; Wand G; Mishra C; George N; McDonald M; Lesniak W; Holt DP; Azad BB; Dannals RF; Kem W; Freedman R; Gjedde A Int J Neuropsychopharmacol; 2018 Jul; 21(7):656-667. PubMed ID: 29522184 [TBL] [Abstract][Full Text] [Related]
45. Development of Nag S; Miranda-Azpiazu P; Jia Z; Datta P; Arakawa R; Moein MM; Yang Z; Tu Y; Lemoine L; Ågren H; Nordberg A; Långström B; Halldin C ACS Chem Neurosci; 2022 Feb; 13(3):352-362. PubMed ID: 35020351 [TBL] [Abstract][Full Text] [Related]
46. Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship. Wishka DG; Walker DP; Yates KM; Reitz SC; Jia S; Myers JK; Olson KL; Jacobsen EJ; Wolfe ML; Groppi VE; Hanchar AJ; Thornburgh BA; Cortes-Burgos LA; Wong EH; Staton BA; Raub TJ; Higdon NR; Wall TM; Hurst RS; Walters RR; Hoffmann WE; Hajos M; Franklin S; Carey G; Gold LH; Cook KK; Sands SB; Zhao SX; Soglia JR; Kalgutkar AS; Arneric SP; Rogers BN J Med Chem; 2006 Jul; 49(14):4425-36. PubMed ID: 16821801 [TBL] [Abstract][Full Text] [Related]
47. Synthesis, nicotinic acetylcholine receptor binding, antinociceptive and seizure properties of methyllycaconitine analogs. Ivy Carroll F; Ma W; Navarro HA; Abraham P; Wolckenhauer SA; Damaj MI; Martin BR Bioorg Med Chem; 2007 Jan; 15(2):678-85. PubMed ID: 17098430 [TBL] [Abstract][Full Text] [Related]
48. Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor. Faghih R; Gfesser GA; Gopalakrishnan M Recent Pat CNS Drug Discov; 2007 Jun; 2(2):99-106. PubMed ID: 18221220 [TBL] [Abstract][Full Text] [Related]
49. The alpha7 nicotinic receptor agonist SSR180711 increases activity regulated cytoskeleton protein (Arc) gene expression in the prefrontal cortex of the rat. Kristensen SE; Thomsen MS; Hansen HH; Timmermann DB; Hay-Schmidt A; Mikkelsen JD Neurosci Lett; 2007 May; 418(2):154-8. PubMed ID: 17379406 [TBL] [Abstract][Full Text] [Related]
50. T cells express alpha7-nicotinic acetylcholine receptor subunits that require a functional TCR and leukocyte-specific protein tyrosine kinase for nicotine-induced Ca2+ response. Razani-Boroujerdi S; Boyd RT; Dávila-García MI; Nandi JS; Mishra NC; Singh SP; Pena-Philippides JC; Langley R; Sopori ML J Immunol; 2007 Sep; 179(5):2889-98. PubMed ID: 17709503 [TBL] [Abstract][Full Text] [Related]
51. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists. Kroker KS; Moreth J; Kussmaul L; Rast G; Rosenbrock H Brain Res Bull; 2013 Jul; 96():28-38. PubMed ID: 23639920 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates. Bois F; Gallezot JD; Zheng MQ; Lin SF; Esterlis I; Cosgrove KP; Carson RE; Huang Y Nucl Med Biol; 2015 Jun; 42(6):570-7. PubMed ID: 25858513 [TBL] [Abstract][Full Text] [Related]
53. Radioligand binding characterization of neuronal nicotinic acetylcholine receptors. Anderson DJ Curr Protoc Pharmacol; 2008 Dec; Chapter 1():Unit1.8. PubMed ID: 22294217 [TBL] [Abstract][Full Text] [Related]
54. Pharmacological characterization of [(125)I]CHIBA-1006 binding, a new radioligand for α7 nicotinic acetylcholine receptors, to rat brain membranes. Wu J; Toyohara J; Tanibuchi Y; Fujita Y; Zhang J; Chen H; Matsuo M; Wang RF; Hashimoto K Brain Res; 2010 Nov; 1360():130-7. PubMed ID: 20816767 [TBL] [Abstract][Full Text] [Related]
55. [(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR. Gao Y; Mease RC; Olson TT; Kellar KJ; Dannals RF; Pomper MG; Horti AG Nucl Med Biol; 2015 May; 42(5):488-493. PubMed ID: 25687449 [TBL] [Abstract][Full Text] [Related]
56. Selectivity optimization of substituted 1,2,3-triazoles as α7 nicotinic acetylcholine receptor agonists. Arunrungvichian K; Fokin VV; Vajragupta O; Taylor P ACS Chem Neurosci; 2015 Aug; 6(8):1317-30. PubMed ID: 25932897 [TBL] [Abstract][Full Text] [Related]
57. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro. Rousseau SJ; Jones IW; Pullar IA; Wonnacott S Neuropharmacology; 2005 Jul; 49(1):59-72. PubMed ID: 15992581 [TBL] [Abstract][Full Text] [Related]
58. Radiosynthesis of (S)-[ Sarasamkan J; Fischer S; Deuther-Conrad W; Ludwig FA; Scheunemann M; Arunrungvichian K; Vajragupta O; Brust P Appl Radiat Isot; 2017 Jun; 124():106-113. PubMed ID: 28365525 [TBL] [Abstract][Full Text] [Related]
59. Localized infusions of the partial alpha 7 nicotinic receptor agonist SSR180711 evoke rapid and transient increases in prefrontal glutamate release. Bortz DM; Mikkelsen JD; Bruno JP Neuroscience; 2013; 255():55-67. PubMed ID: 24095692 [TBL] [Abstract][Full Text] [Related]
60. Uptake of nicotinic acetylcholine receptor imaging agent is reduced in the pro-inflammatory macrophage. Suzuki M; Katayama T; Suzuki C; Nakajima K; Magata Y; Ogawa M Nucl Med Biol; 2021; 102-103():45-55. PubMed ID: 34619460 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]